vs

Side-by-side financial comparison of PETMED EXPRESS INC (PETS) and Playboy, Inc. (PLBY). Click either name above to swap in a different company.

PETMED EXPRESS INC is the larger business by last-quarter revenue ($40.7M vs $34.9M, roughly 1.2× Playboy, Inc.). Playboy, Inc. runs the higher net margin — 10.3% vs -26.0%, a 36.2% gap on every dollar of revenue. On growth, Playboy, Inc. posted the faster year-over-year revenue change (4.2% vs -23.3%). Playboy, Inc. produced more free cash flow last quarter ($1.1M vs $-9.2M). Over the past eight quarters, Playboy, Inc.'s revenue compounded faster (11.0% CAGR vs -20.9%).

PetMed Express, Inc., also known as PetMeds, is an online pet pharmacy based in the United States. It is publicly traded and sells prescription and non-prescription pet medication.

Playboy is an American men's lifestyle and entertainment magazine, available both online and in print. It was founded in Chicago in 1953 by Hugh Hefner and his associates, funded in part by a $1,000 loan from Hefner's mother.

PETS vs PLBY — Head-to-Head

Bigger by revenue
PETS
PETS
1.2× larger
PETS
$40.7M
$34.9M
PLBY
Growing faster (revenue YoY)
PLBY
PLBY
+27.5% gap
PLBY
4.2%
-23.3%
PETS
Higher net margin
PLBY
PLBY
36.2% more per $
PLBY
10.3%
-26.0%
PETS
More free cash flow
PLBY
PLBY
$10.3M more FCF
PLBY
$1.1M
$-9.2M
PETS
Faster 2-yr revenue CAGR
PLBY
PLBY
Annualised
PLBY
11.0%
-20.9%
PETS

Income Statement — Q3 FY2026 vs Q4 FY2025

Metric
PETS
PETS
PLBY
PLBY
Revenue
$40.7M
$34.9M
Net Profit
$-10.6M
$3.6M
Gross Margin
23.3%
73.3%
Operating Margin
-25.7%
7.9%
Net Margin
-26.0%
10.3%
Revenue YoY
-23.3%
4.2%
Net Profit YoY
-1392.6%
128.6%
EPS (diluted)
$-0.50
$0.05

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
PETS
PETS
PLBY
PLBY
Q4 25
$40.7M
$34.9M
Q3 25
$44.4M
$29.0M
Q2 25
$51.2M
$28.1M
Q1 25
$50.8M
$28.9M
Q4 24
$52.0M
$33.5M
Q3 24
$58.0M
$29.4M
Q2 24
$66.2M
$24.9M
Q1 24
$65.1M
$28.3M
Net Profit
PETS
PETS
PLBY
PLBY
Q4 25
$-10.6M
$3.6M
Q3 25
$-8.5M
$460.0K
Q2 25
$-34.2M
$-7.7M
Q1 25
$-11.6M
$-9.0M
Q4 24
$-707.0K
$-12.5M
Q3 24
$2.3M
$-33.8M
Q2 24
$3.8M
$-16.7M
Q1 24
$-5.0M
$-16.4M
Gross Margin
PETS
PETS
PLBY
PLBY
Q4 25
23.3%
73.3%
Q3 25
28.0%
76.0%
Q2 25
28.1%
65.4%
Q1 25
29.9%
68.6%
Q4 24
31.0%
70.8%
Q3 24
32.3%
61.0%
Q2 24
28.8%
67.8%
Q1 24
29.3%
55.8%
Operating Margin
PETS
PETS
PLBY
PLBY
Q4 25
-25.7%
7.9%
Q3 25
-18.9%
4.7%
Q2 25
-66.7%
-20.9%
Q1 25
-11.9%
-21.7%
Q4 24
-0.9%
-13.3%
Q3 24
1.0%
-96.0%
Q2 24
6.6%
-37.0%
Q1 24
-5.9%
-31.5%
Net Margin
PETS
PETS
PLBY
PLBY
Q4 25
-26.0%
10.3%
Q3 25
-19.2%
1.6%
Q2 25
-66.7%
-27.3%
Q1 25
-22.9%
-31.3%
Q4 24
-1.4%
-37.4%
Q3 24
4.0%
-114.7%
Q2 24
5.7%
-66.9%
Q1 24
-7.7%
-58.1%
EPS (diluted)
PETS
PETS
PLBY
PLBY
Q4 25
$-0.50
$0.05
Q3 25
$-0.41
$0.00
Q2 25
$-1.65
$-0.08
Q1 25
$-0.56
$-0.10
Q4 24
$-0.03
$-0.13
Q3 24
$0.11
$-0.45
Q2 24
$0.18
$-0.23
Q1 24
$-0.24
$-0.23

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
PETS
PETS
PLBY
PLBY
Cash + ST InvestmentsLiquidity on hand
$26.9M
$37.8M
Total DebtLower is stronger
$174.2M
Stockholders' EquityBook value
$32.8M
$18.4M
Total Assets
$88.0M
$292.4M
Debt / EquityLower = less leverage
9.48×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
PETS
PETS
PLBY
PLBY
Q4 25
$26.9M
$37.8M
Q3 25
$36.1M
$27.5M
Q2 25
$41.1M
$19.6M
Q1 25
$54.7M
$23.7M
Q4 24
$50.1M
$30.9M
Q3 24
$52.0M
$9.5M
Q2 24
$46.0M
$16.9M
Q1 24
$55.3M
$19.0M
Total Debt
PETS
PETS
PLBY
PLBY
Q4 25
$174.2M
Q3 25
$176.8M
Q2 25
$177.5M
Q1 25
$176.3M
Q4 24
$176.6M
Q3 24
$200.0M
Q2 24
$196.3M
Q1 24
$193.4M
Stockholders' Equity
PETS
PETS
PLBY
PLBY
Q4 25
$32.8M
$18.4M
Q3 25
$43.1M
$3.8M
Q2 25
$51.5M
$-17.5M
Q1 25
$85.1M
$-11.4M
Q4 24
$96.2M
$-7.7M
Q3 24
$96.4M
$-15.7M
Q2 24
$93.5M
$15.7M
Q1 24
$96.7M
$29.5M
Total Assets
PETS
PETS
PLBY
PLBY
Q4 25
$88.0M
$292.4M
Q3 25
$100.3M
$278.3M
Q2 25
$109.8M
$264.1M
Q1 25
$148.7M
$270.6M
Q4 24
$144.8M
$284.7M
Q3 24
$146.0M
$271.5M
Q2 24
$152.7M
$301.8M
Q1 24
$169.9M
$309.1M
Debt / Equity
PETS
PETS
PLBY
PLBY
Q4 25
9.48×
Q3 25
46.86×
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
12.51×
Q1 24
6.54×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
PETS
PETS
PLBY
PLBY
Operating Cash FlowLast quarter
$-9.2M
$1.4M
Free Cash FlowOCF − Capex
$-9.2M
$1.1M
FCF MarginFCF / Revenue
-22.7%
3.2%
Capex IntensityCapex / Revenue
0.1%
0.8%
Cash ConversionOCF / Net Profit
0.39×
TTM Free Cash FlowTrailing 4 quarters
$-23.0M
$-1.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
PETS
PETS
PLBY
PLBY
Q4 25
$-9.2M
$1.4M
Q3 25
$-2.2M
$10.1M
Q2 25
$-12.3M
$-3.9M
Q1 25
$7.0M
$-7.6M
Q4 24
$-1.2M
$161.0K
Q3 24
$7.4M
$-6.5M
Q2 24
$-8.5M
$-3.0M
Q1 24
$7.1M
$-9.8M
Free Cash Flow
PETS
PETS
PLBY
PLBY
Q4 25
$-9.2M
$1.1M
Q3 25
$-4.8M
$9.8M
Q2 25
$-13.6M
$-4.3M
Q1 25
$4.6M
$-7.7M
Q4 24
$-1.9M
$-401.0K
Q3 24
$6.1M
$-7.0M
Q2 24
$-9.2M
$-3.7M
Q1 24
$5.9M
$-10.3M
FCF Margin
PETS
PETS
PLBY
PLBY
Q4 25
-22.7%
3.2%
Q3 25
-10.8%
33.8%
Q2 25
-26.5%
-15.2%
Q1 25
9.1%
-26.5%
Q4 24
-3.7%
-1.2%
Q3 24
10.6%
-23.7%
Q2 24
-13.9%
-14.8%
Q1 24
9.0%
-36.5%
Capex Intensity
PETS
PETS
PLBY
PLBY
Q4 25
0.1%
0.8%
Q3 25
5.9%
1.1%
Q2 25
2.5%
1.4%
Q1 25
4.7%
0.1%
Q4 24
1.5%
1.7%
Q3 24
2.2%
1.5%
Q2 24
1.0%
2.6%
Q1 24
1.9%
2.1%
Cash Conversion
PETS
PETS
PLBY
PLBY
Q4 25
0.39×
Q3 25
22.02×
Q2 25
Q1 25
Q4 24
Q3 24
3.18×
Q2 24
-2.27×
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

PETS
PETS

Reorder$34.0M84%
New Order$5.0M12%
Membership Fees$1.6M4%

PLBY
PLBY

Transferred At Point In Time$22.2M64%
Trademark Licensing$6.5M19%
Related Party$5.0M14%
Other$1.1M3%

Related Comparisons